Author/Authors :
Shariff, Atiqulla Department of Clinical Pharmacy and Pharmacology - RAK College of Pharmaceutical Sciences - RAK Medical and Health Sciences University, Ras Al Khaimah, United Arab Emirates , Belagodu Sridhar, Sathvik Department of Clinical Pharmacy and Pharmacology - RAK College of Pharmaceutical Sciences - RAK Medical and Health Sciences University, Ras Al Khaimah, United Arab Emirates , Rami Bittar, Hana Department of Clinical Pharmacy and Pharmacology - RAK College of Pharmaceutical Sciences - RAK Medical and Health Sciences University, Ras Al Khaimah, United Arab Emirates , Hamad, Ahed Department of Clinical Pharmacy and Pharmacology - RAK College of Pharmaceutical Sciences - RAK Medical and Health Sciences University, Ras Al Khaimah, United Arab Emirates , Ahmed, Reem Department of Clinical Pharmacy and Pharmacology - RAK College of Pharmaceutical Sciences - RAK Medical and Health Sciences University, Ras Al Khaimah, United Arab Emirates , Kadour, Ghaidaa Department of Clinical Pharmacy and Pharmacology - RAK College of Pharmaceutical Sciences - RAK Medical and Health Sciences University, Ras Al Khaimah, United Arab Emirates
Abstract :
Objective: Hypoglycemia is the most common complication of the treatment
for diabetes mellitus. Various factors predispose an individual for drug‐induced
hypoglycemia. The aim of this study was to explore the relative frequency and
likely predisposing factors for drug‐induced hypoglycemia among type‐2 diabetic
patients in the United Arab Emirates (UAE). Methods: In this cross-sectional
survey‐based study which was conducted from February to April 2018 in
two local community pharmacies in the UAE, diabetic patients underwent a
structured interview on their diabetes mellitus status and management and specific
open‐ended questions related to hypoglycemic symptoms that they might have
experienced and the occurrence of symptoms. Collected data were used to estimate
the relative frequency of drug‐induced hypoglycemia and to identify the probable
predisposing factors and their contribution in causing hypoglycemia using relative
risk, Chi‐square test, and Fisher’s exact test. Findings: The relative frequency of
drug‐induced hypoglycemia in our study was 46.25%. Patients’ age of ≥65 years,
duration of diabetes mellitus for more than 1 year, patients with more than one
comorbid condition, and patients using more than one antidiabetic medication were
predisposing for developing drug‐induced hypoglycemia. Conclusion: The relative
frequency of drug‐induced hypoglycemia in a nontrial environment which lacks
the special cares routinely provided in drug development clinical trials is high.
We suggest that more attention should be paid to identify, prevent, and manage
drug‐induced hypoglycemia in type‐2 diabetic patients who have more than
1 year of diabetes, more than one comorbidity, using more than one antidiabetic
medication, and elderly.
Keywords :
Drug‐induced hypoglycemia , predisposing factors , relative frequency , type‐2 diabetes mellitus